INSYS THERAPEUTICS (INSY) Covered Calls

INSYS THERAPEUTICS covered calls Insys Therapeutics Inc is a commercial-stage specialty pharmaceutical company that develops and commercializes innovative supportive care products. Its two marketed products include Subsys and Dronabinol SG Capsule.

You can sell covered calls on INSYS THERAPEUTICS to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for INSY (prices last updated Mon 4:16 PM ET):

INSYS THERAPEUTICS (INSY) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
9.44 +0.29 9.40 9.44 565K - 0.7B
Covered Calls For INSYS THERAPEUTICS (INSY)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Oct 19 9 0.85 8.59 4.8% 67.4%
Nov 16 9 1.20 8.24 9.2% 62.2%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

INSYS Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company, which develops and commercializes supportive care products. It focuses on utilizing its proprietary formulation technologies to address the clinical shortcomings of existing commercial pharmaceutical products. The company markets Subsys, a proprietary sublingual fentanyl spray for breakthrough pain in opioid-tolerant cancer patients; and Dronabinol Oral Solution, a proprietary orally administered liquid formulation of dronabinol. It offers its Subsys through its incentive-based commercial sales force. The company also provides Dronabinol SG Capsule, a generic equivalent to Marinol, an approved second-line treatment for chemotherapy-induced nausea and vomiting, and anorexia associated with weight loss in patients with AIDS. INSYS Therapeutics was founded by John N. Kapoor on June 15, 1990 and is headquartered in Chandler, AZ.